Tranexamic Acid
- Product NDC
- 72611-760
- 11-digit product format
- 726110760
- Labeler code
- 72611
- Product ID
- 72611-760_dcdf3a21-e589-e641-5a56-afbf0a6e738a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tranexamic acid
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Almaject, Inc.
- Application
- ANDA207239
- Marketing category
- ANDA
- Marketing start
- 2021-03-01
- Marketing end
- 0000-00-00
- Substance
- TRANEXAMIC ACID
- Active strength
- 100 mg/mL
- Pharmacologic classes
- Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 72611-760-10 | 72611076010 | 10 VIAL, SINGLE-DOSE in 1 CARTON (72611-760-10) > 10 mL in 1 VIAL, SINGLE-DOSE (72611-760-01) | 2021-03-01 | 0000-00-00 | No | No | Current |